DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 1Dr. Reddy's Laboratories
02 8Alfred E Tiefenbacher GmbH
03 3Aucta Pharmaceuticals
04 1Strides Pharma Science
05 4ANGITA PHARMA INC.
06 20Accord healthcare
07 4Actavis Inc
08 4Alembic Pharmaceuticals Limited
09 5Alkem Laboratories
10 17Alphapharm PTY Ltd
11 5Amneal Pharmaceuticals
12 6Apotex Inc
13 4Aristo Pharma GmbH
14 17Arrotex Pharmaceuticals
15 1Aspiro Pharma
16 4Auro Pharma Inc
17 10Aurobindo Pharma Limited
18 1Chartwell Pharmaceuticals llc
19 9Cipla
20 5DOC Generici
21 11Desitin Arzneimittel
22 6EG Spa
23 6Ecupharma
24 1Fresenius Kabi USA
25 1GLAND PHARMA LIMITED
26 17Generic Health
27 5Glenmark Pharmaceuticals
28 1Hainan Poly Pharm
29 2Hameln Pharma GmbH
30 5Hetero Drugs
31 2Hikma Pharmaceuticals
32 9Indoco Remedies Limited
33 4Intas Pharmaceuticals
34 4JAMP PHARMA
35 4KANCHAN HLTHCARE
36 2Kolmar Korea Co., Ltd.
37 6Krka
38 1Leading Pharma, LLC
39 4MINT PHARMACEUTICALS INC
40 6MSN Laboratories
41 8Macleods Pharmaceuticals Limited
42 4Medical Valley
43 10Mepha Pharma
44 5Neuraxpharm
45 4Nora Pharma
46 1Novitium Pharma LLC
47 4ORIFARM GROUP AS
48 4Orchid Pharma
49 21Pharmacore Inc
50 4Pharmascience Inc.
51 4SANIS HEALTH INC
52 5SF Group
53 39Sandoz B2B
54 4ScieGen Pharmaceuticals
55 4So.Se.Pharm
56 1Somerset Pharmaceuticals Inc
57 4Sun Pharmaceutical Industries Limited
58 5Tecnimede
59 14Teva Pharmaceutical Industries
60 4Torrent Pharmaceuticals Limited
61 86UCB Pharma S.A
62 4Unichem Laboratories Limited
63 4Unichem Pharmaceuticals USA, Inc
64 6Viatris
65 10Zentiva
66 5Zydus Pharmaceuticals
01 7Antic-calc Tablet, Film Coated
02 3CAPSULE, EXTENDED RELEASE;ORAL
03 4Effervescent Tablet
04 5FILMDRAGERAD TABLETT
05 16Film Coated Tablet
06 2Film Coated Tablets
07 5Film-Coated Tablet
08 2Film-Coated Tablet Oral Use Blister
09 71Film-Coated Tablets
10 4Film-Coated Tablets Oral Use Blister
11 4Filmcoated Tablets Oral
12 8Filmtab
13 15Filmtabl
14 1INFUSIONSVÄTSKA, LÖSNING
15 1Infusion fluid, resolution
16 1Lacosamide 100Mg 14 Joined' Oral Use
17 1Lacosamide 100Mg 56 Combined Oral Use
18 1Lacosamide 150Mg 14 Joined' Oral Use
19 1Lacosamide 150Mg 56 Combined Oral Use
20 1Lacosamide 200Mg 56 Combined Oral Use
21 1Lacosamide 50Mg 14 Joined' Oral Use
22 1Lacosamide 50Mg 56 Combined Oral Use
23 10Lactab
24 2SIRAP
25 2SOLUTION
26 12SOLUTION;INTRAVENOUS
27 11SOLUTION;ORAL
28 1Sirup
29 4Solution for infusion
30 6Syrup
31 4TAB
32 48TABLET
33 76TABLET;ORAL
34 14Tablet
35 20Tablet, film-coated
36 69tablet
37 56Blank
01 17DISCN
02 12Generic
03 4Generic EU CTD
04 46Prescription
05 80RX
06 8Registered in EU
07 323Blank
01 4ACH-LACOSAMIDE
02 4AG-LACOSAMIDE
03 4AURO-LACOSAMIDE
04 4JAMP-LACOSAMIDE
05 97LACOSAMIDE
06 6LACOSAMIDE ACCORD
07 4LACOSAMIDE ARISTO
08 5LACOSAMIDE AUROBINDO
09 5LACOSAMIDE DOC
10 6LACOSAMIDE EG
11 1LACOSAMIDE INJECTION, USP
12 6LACOSAMIDE KRKA
13 6LACOSAMIDE MYLAN
14 6LACOSAMIDE SANDAZ
15 6LACOSAMIDE TEVA
16 6LACOSAMIDE ZENTIVA
17 4LAPRYSTA
18 9Lacoress
19 17Lacosam
20 11Lacosamid Desitin
21 6Lacosamid Sandoz
22 8Lacosamid-Mepha
23 17Lacosamide ARX
24 6Lacosamide Accord
25 17Lacosamide Lupin
26 4Lacosamide Medical Valley
27 23Lacosamide Sandoz
28 2Lacosamide hameln
29 2Lacosamide-Mepha
30 4MINT-LACOSAMIDE
31 3MOTPOLY XR
32 5NEPILEX
33 4NRA-LACOSAMIDE
34 4OLLAT
35 4PHARMA-LACOSAMIDE
36 4SANDOZ LACOSAMIDE
37 6STUTAN
38 4TEVA-LACOSAMIDE
39 1VIMCOSA 100 mg
40 1VIMCOSA 150 mg
41 1VIMCOSA 200 mg
42 1VIMCOSA 50 mg
43 17VIMPAT
44 21Vimcosa
45 2Vimcosa Tablet
46 66Vimpat
47 7Vpat
48 39Blank
01 125Australia
02 46Canada
03 4Czech Republic
04 8Germany
05 21India
06 88Italy
07 34Norway
08 5Portugal
09 4South Africa
10 2South Korea
11 1Spain
12 8Sweden
13 42Switzerland
14 102USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : LACOSAMIDE
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 200MG/20ML (10MG/ML)
Packaging :
Approval Date : 2024-03-25
Application Number : 217718
Regulatory Info : RX
Registration Country : USA
Regulatory Info : Registered in EU
Registration Country : Germany
Brand Name :
Dosage Form : Film Coated Tablet
Dosage Strength : 50MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Registered in EU
Registration Country : Germany
Regulatory Info : RX
Registration Country : USA
Brand Name : MOTPOLY XR
Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL
Dosage Strength : 100MG
Packaging :
Approval Date : 2023-05-04
Application Number : 216185
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Syrup
Dosage Strength : 10MG/ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info : Registered in EU
Registration Country : Germany
Brand Name :
Dosage Form : Film Coated Tablet
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Registered in EU
Registration Country : Germany
Regulatory Info : Registered in EU
Registration Country : Germany
Brand Name :
Dosage Form : Film Coated Tablet
Dosage Strength : 150MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Registered in EU
Registration Country : Germany
Regulatory Info : Registered in EU
Registration Country : Germany
Brand Name :
Dosage Form : Film Coated Tablet
Dosage Strength : 200MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Registered in EU
Registration Country : Germany
Regulatory Info : Registered in EU
Registration Country : Germany
Brand Name :
Dosage Form : Film Coated Tablet
Dosage Strength : 50MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Registered in EU
Registration Country : Germany
Regulatory Info : Registered in EU
Registration Country : Germany
Brand Name :
Dosage Form : Film Coated Tablet
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Registered in EU
Registration Country : Germany
Regulatory Info : Registered in EU
Registration Country : Germany
Brand Name :
Dosage Form : Film Coated Tablet
Dosage Strength : 150MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Registered in EU
Registration Country : Germany
Regulatory Info : Registered in EU
Registration Country : Germany
Brand Name :
Dosage Form : Film Coated Tablet
Dosage Strength : 200MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Registered in EU
Registration Country : Germany
Regulatory Info : RX
Registration Country : USA
Brand Name : MOTPOLY XR
Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL
Dosage Strength : 150MG
Packaging :
Approval Date : 2023-05-04
Application Number : 216185
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : MOTPOLY XR
Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL
Dosage Strength : 200MG
Packaging :
Approval Date : 2023-05-04
Application Number : 216185
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : Norway
Brand Name : Lacosamide hameln
Dosage Form : Solution for infusion
Dosage Strength : 10 mg/ml
Packaging : Vials 5 20ml
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info : RX
Registration Country : USA
Brand Name : LACOSAMIDE
Dosage Form : TABLET;ORAL
Dosage Strength : 50MG
Packaging :
Approval Date : 2022-03-17
Application Number : 204787
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : LACOSAMIDE
Dosage Form : TABLET;ORAL
Dosage Strength : 100MG
Packaging :
Approval Date : 2022-03-17
Application Number : 204787
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : Norway
Brand Name : Lacosamide Medical Valley
Dosage Form : Tablet, film-coated
Dosage Strength : 50 mg
Packaging : Blisterpakning 56item
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Norway
Brand Name : Lacosamide Medical Valley
Dosage Form : Tablet, film-coated
Dosage Strength : 200 mg
Packaging : Blisterpakning 56item
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Norway
Brand Name : Lacosamide Medical Valley
Dosage Form : Tablet, film-coated
Dosage Strength : 150 mg
Packaging : Blisterpakning 56item
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Norway
Brand Name : Lacosamide Medical Valley
Dosage Form : Tablet, film-coated
Dosage Strength : 100 mg
Packaging : Blisterpakning 56item
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Norway
Brand Name : Vimpat
Dosage Form : Tablet, film-coated
Dosage Strength : 150 mg
Packaging : Blisterpakning 56item
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Norway
Brand Name : Vimpat
Dosage Form : Tablet, film-coated
Dosage Strength : 100 mg
Packaging : Blisterpakning 56item
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Norway
Brand Name : Vimpat
Dosage Form : Tablet, film-coated
Dosage Strength : 200 mg
Packaging : Blisterpakning 56item
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Norway
Brand Name : Vimpat
Dosage Form : Tablet, film-coated
Dosage Strength : 50 mg
Packaging : Blisterpakning 56item
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info : RX
Registration Country : USA
Brand Name : VIMPAT
Dosage Form : TABLET;ORAL
Dosage Strength : 50MG
Packaging :
Approval Date : 2008-10-28
Application Number : 22253
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : VIMPAT
Dosage Form : TABLET;ORAL
Dosage Strength : 100MG
Packaging :
Approval Date : 2008-10-28
Application Number : 22253
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : VIMPAT
Dosage Form : TABLET;ORAL
Dosage Strength : 150MG
Packaging :
Approval Date : 2008-10-28
Application Number : 22253
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : VIMPAT
Dosage Form : TABLET;ORAL
Dosage Strength : 200MG
Packaging :
Approval Date : 2008-10-28
Application Number : 22253
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : VIMPAT
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 200MG/20ML (10MG/ML)
Packaging :
Approval Date : 2008-10-28
Application Number : 22254
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : VIMPAT
Dosage Form : SOLUTION;ORAL
Dosage Strength : 10MG/ML
Packaging :
Approval Date : 2010-04-20
Application Number : 22255
Regulatory Info : RX
Registration Country : USA
LOOKING FOR A SUPPLIER?